Cognios Capital’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,375
Closed -$511K 70
2020
Q1
$511K Sell
6,375
-17,249
-73% -$1.79M 0.26% 119
2019
Q4
$2.52M Sell
23,624
-14,315
-38% -$1.49M 0.89% 33
2019
Q3
$4.06M Buy
37,939
+357
+0.9% +$36.6K 1.5% 7
2019
Q2
$3.83M Buy
37,582
+33,916
+925% +$3.26M 1.47% 11
2019
Q1
$329K Buy
3,666
+6
+0.2% +$520 0.12% 126
2018
Q4
$304K Buy
3,660
+373
+11% +$35K 0.12% 127
2018
Q3
$354K Sell
3,287
-19,972
-86% -$2.19M 0.15% 128
2018
Q2
$2.56M Sell
23,259
-2,279
-9% -$237K 0.89% 32
2018
Q1
$2.56M Buy
25,538
+34
+0.1% +$3.48K 0.93% 20
2017
Q4
$2.51M Buy
25,504
+1,096
+4% +$104K 0.95% 19
2017
Q3
$2.29M Sell
24,408
-6,399
-21% -$679K 0.92% 27
2017
Q2
$3.42M Sell
30,807
-7,943
-20% -$840K 1.2% 14
2017
Q1
$3.8M Sell
38,750
-4,917
-11% -$469K 1.26% 23
2016
Q4
$4.01M Sell
43,667
-6,294
-13% -$542K 1.22% 29
2016
Q3
$4.23M Buy
49,961
+47,032
+1,606% +$3.95M 1.21% 26
2016
Q2
$238K Buy
2,929
+10
+0.3% +$761 0.08% 96
2016
Q1
$208K Buy
2,919
+9
+0.3% +$604 0.08% 103
2015
Q4
$207K Buy
+2,910
New +$196K 0.11% 111
2015
Q2
Sell
-56,369
Closed -$4.33M 95
2015
Q1
$4.33M Buy
+56,369
New +$4.04M 2.55% 15
2014
Q3
Sell
-4,085
Closed -$239K 82
2014
Q2
$239K Buy
4,085
+526
+15% +$30.8K 0.17% 74
2014
Q1
$206K Buy
+3,559
New +$191K 0.12% 67

Other funds holding DGX

Cognios Capital's DGX Position: Q2 2020 in Review

Cognios Capital sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 6,375 shares — an estimated $511K sold.

Cognios Capital first reported a position in DGX in Q1 2014 and held it in 21 quarters. The position peaked at $4.33M in Q1 2015. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Cognios Capital reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Cognios Capital sold 6,375 Quest Diagnostics shares in Q2 2020, an estimated $511K.
  • Cognios Capital first reported a position in Quest Diagnostics in Q1 2014 and held it in 21 quarters.
  • Cognios Capital's Quest Diagnostics position peaked at $4.33M in Q1 2015.
  • 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Cognios Capital's 13F filing for Q2 2020.